(Q35161097)

English

Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

inflammatory bowel diseases

0 references

author name string

Rutgeerts P

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Van Deventer S

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Schreiber S

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1435-1450

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

A critical assessment of new therapies in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Side effects of corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Pharmacokinetics of budesonide controlled ileal release capsules in children and adults with active Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

NOD2/CARD15 does not influence response to infliximab in Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Treatment of ulcerative colitis with an engineered human anti-TNFalpha antibody CDP571.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Review article: does the use of immunosuppressive therapy in inflammatory bowel disease increase the risk of developing lymphoma?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Drug-induced lupus following treatment with infliximab in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Integrins: bidirectional, allosteric signaling machines

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Integrins as mediators of epithelial cell-matrix interactions in the human small intestinal mucosa

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Subcellular localization of intercellular adhesion molecule-1 in colonic mucosa in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Primary structure of the leukocyte function-associated molecule-1 alpha subunit: an integrin with an embedded domain defining a protein superfamily

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Comparative studies of the colonic in situ expression of intercellular adhesion molecules (ICAM-1, -2, and -3), beta2 integrins (LFA-1, Mac-1, and p150,95), and PECAM-1 in ulcerative colitis and Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Impaired sensitivity to beta 2 integrin-blocking in ICAM-1-mediated neutrophil migration in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Assessment of the genotoxic potential of ISIS 2302: a phosphorothioate oligodeoxynucleotide.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

The integrin very late antigen-4 is expressed in human smooth muscle cell. Involvement of alpha 4 and vascular cell adhesion molecule-1 during smooth muscle cell differentiation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Distinct roles of L-selectin and integrins alpha 4 beta 7 and LFA-1 in lymphocyte homing to Peyer's patch-HEV in situ: the multistep model confirmed and refined

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Alpha 4 beta 1 integrin/VCAM-1 interaction activates alpha L beta 2 integrin-mediated adhesion to ICAM-1 in human T cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Role of integrin alpha 4 beta 7/alpha 4 beta P in lymphocyte adherence to fibronectin and VCAM-1 and in homotypic cell clustering

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Integrin alpha4beta7 mediates human eosinophil interaction with MAdCAM-1, VCAM-1 and fibronectin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Natalizumab for active Crohn's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

A controlled trial of natalizumab for relapsing multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Response to infliximab treatment in Crohn's disease is not associated with mutations in the CARD15 (NOD2) gene: an analysis in 534 patients from two multicenter, prospective GCP-level trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01603.X

21 January 2018

Identifiers

10.1046/J.1365-2036.2003.01603.X

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35161097&oldid=1572090249"